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Abstract
Background:
Some diseases that affect the visual system may show loss of chromatic-achromatic sensitivity before
obvious physical signs appear in the usual examination of the eye's posterior segment. A perimetric study
has been conducted with four typical patients with glaucoma and diabetes, at different stages of the
disease.
Materials and Methods:
In addition to the standard white-on-white (standard automated perimetry [SAP]), a test battery has been
used to study patient's contrast sensitivity, using stimuli with different chromatic, spatial, and temporal
content (multichannel perimetry). The choice of stimuli tries to maximize the response of different visual
mechanisms: Achromatic (parvocellular and magnocellular origin); chromatic red-green (parvocellular
origin); and chromatic blue-yellow (koniocellular origin).
Results:
The results seem to indicate losses in the achromatic-parvocellular perimetry and both chromatic perimetry
tests, undetected by conventional SAP.
Conclusions:
Our results illustrate that our patients without visible retinal alterations show signs of suspicion in
multichannel perimetry.
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Color perimetry has interesting clinical application for the diagnosis and detection of certain eye
conditions, due to the variations that certain diseases can cause in chromatic thresholds, both in the red-
green (RG) and the blue-yellow (BY) pathways.[1,2,3,4]
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The separate study of the visual function of both the chromatic and achromatic mechanisms could be more
efficient in detecting sensitivity variations, and such variations would not be obscured by the intrusion of
other mechanisms. Currently, the supply of conventional perimeters that are capable of performing a
chromatic perimetry test is very limited and with reduced options regarding the possibility of choosing the
physical characteristics of the stimulus (see Monhart[5] for a review of the available techniques).
For the study that we have carried out, we have used a multichannel perimetric technique, which provides
the user with the choice of a wide range of characteristics of the stimulus, such as chromaticity, spatial and
temporal frequency, size, duration or border smoothing.[6,7] It allows measurements of contrast sensitivity
in different directions of the color space and with stimuli with different space-time features with a dual
objective: to determine in which pathway the losses are greater and to maximize the probability of
detecting these losses by modifying the detectability of the stimuli by means of their spatiotemporal
frequency content. This procedure has the additional advantage of yielding results that can readily be
compared between stimuli, since the task performed by the observer is always the same.
With this technique, we hope to detect early functional losses, before clinical signs are observable or in the
asymptomatic stages, which with conventional perimetry testing could still go unnoticed. The
interpretation of the results would be much easier if we could ensure that in each stimuli used we are
isolating a particular visual mechanism. Unfortunately, although selected stimuli particularly favor a single
mechanism, we cannot be sure of silencing the rest. Mechanism isolation would improve the ability to
detect loss of functionality of the visual system, according to previous results[8,9,10,11] and this is the
motivation behind different lines of research based in the multichannel perimetry technique used in this
paper.
Focusing in this type of the perimetric test, our aim is to illustrate how different perimetric techniques
contribute to gain a clearer picture of the functional losses experienced by a given patient. To this end, we
show four illustrative cases of two pathologies affecting the visual system (glaucoma and diabetes), at two
stages of the evolution of the disease (patients with and without obvious clinical signs).
Materials and Methods
Four patients, two diabetic (D1 and D2) and two glaucomatous (G1 and G2) subjects, selected for routine
visits at our University Clinic, participated in the study. Labels 1 and 2 indicate the progress of the
pathology, with “1” to indicate an incipient state, with no obvious signs in the retina in a basic
ophthalmological exploration, and “2” to indicate a more advanced state. The study adheres to the tenets of
the Declaration of Helsinki for Research Involving Human Observers.
The patients underwent the following test battery: measurement of visual acuity (VA) with the best visual
correction, air tonometry (TOPCON CT-80, from Topcon Europe Medical B.V. Capelle a/d IJssel,
Netherlands), exploration of the anterior segment (TOPCON IS-600) and of the posterior segment
(TOPCON TRC-NW6S Nonmydriatic Retinal Camera and OPTOPOL SOCT Copernicus HR, from
OPTOPOL Technology Sp. Zawiercie, Poland), study of papillary reaction and symmetry, detection of
alterations of color vision (Farnsworth-Munsell [FM]-100 Hue test, X-Rite Europe GmbH, Regensdorf,
Suiza), SAP test (SBP-3000 TOPCON) and the multichannel perimetry tests.
In the FM-100 Hue test, the total error score (TES) values and the total partial error scores values for the
RG and BY color axes were calculated. These results were compared to typical values corresponding to
the age range of the patient.[12]
For the conventional SAP, we used the fast threshold strategy, with the default parameters (size III stimuli,
0.2 s presentation time and 0.6 s interval time, in an area of 30°). Two global parameters describe overall
sensitivity loss and inhomogeneity in the visual field: The mean defect (MD’) and the loss variance (LV).
MD’ is defined as the mean difference in sensitivity between the standard and the subject, which differs in
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sign from the equivalent parameter used in the multichannel perimeter. The symbol (’) has been introduced
to mark this difference.
Multichannel perimeter
This multichannel perimetry technique has already been used in previous studies.[8,9,10,11] The reader is
referred to the paper by Antón et al.[11] for a thorough explanation of all the details of the device, stimulus
characteristics and measurement method.
In our study, the device evaluates the detection thresholds for spatiotemporal patterns in a 60° horizontal
field by 40° vertical field, centered on the fovea, at a viewing distance of 25 cm. 5° stimulus size, 1 s
maximum presentation time, and 0.5 s maximum, random time interval. Testing points were uniformly
distributed in a 6 × 4 grid covering the visual field, plus a point at the fovea. The measures were carried
out in a dark room, by a staircase procedure. The complete session never exceeded 1 h.
Stimuli can be modulated along the achromatic (A), RG and BY direction of the opponent modulation
space. The spatial and temporal frequency of the pattern can be chosen to favor a particular postreceptorial
mechanism (see Merigan and Maunsell[13] and Dacey,[14] but take into account the objections by
Swanson et al.[15]). Along the achromatic axis two stimuli are used: One stimulus of low spatial frequency
(0.5 cpd) and high temporal frequency (12 Hz), favoring the magnocellular pathway (i.e. A-0.5/12), and
one medium spatial frequency (4 cpd) and low temporal frequency (2 Hz), favoring the parvocellular
pathway (A-4/2).[13] The chromatic RG and BY axes were evaluated with low spatial (0.5 cpd) and
temporal (2 Hz) frequency stimuli.[13] The chromatic properties of these stimuli should favor the parvo
and koniocellular pathways, respectively.
Two global parameters have been used: The MD, or mean deviation, defined as the mean of the differences
between patient and standard observer at each point of the visual field, and the pattern standard deviation
(PSD), defined as the standard deviation of these differences.
Results
We present in the following sub-sections first the results in the preliminary optometric and
ophthalmological exam of the patients, including the results of the FM-100 hue test, and then a global
description of the results obtained in the different perimetry tests.
Optometric and ophthalmological exam
Patient D1
A 35-year-old woman with type-1 insulin-dependent diabetes mellitus of some 20 years of evolution. The
left eye was examined. The basic ophthalmic exploration data are within normal limits (VA, tonometry,
anterior/posterior segment) [Fig. 1a]. The subject shows normal color discrimination with the FM-100 Hue
test, although the RG partial score is larger than for the normal average subject.
Patient D2
A 31-year-old man with type-1 insulin-dependent diabetes mellitus of some 20 years of evolution,
diagnosed with nonproliferative diabetic retinopathy. The right eye was examined. VA, tonometry, and the
exploration of anterior segment are within the normal limits. However, numerous scattered
microaneurysms and hard exudates can be observed in the exploration of the posterior segment [Fig. 1b].
The macula does not present signs of edema, and preserves its structure (hard exudates appear close by, but
they do not protrude into it). Furthermore, pinpoint hemorrhages can be seen. The patient has not been
treated with photocoagulation, but small deposits associated with cholesterol were found in his retina. With
the FM-100 hue test, the patient has normal color discrimination, with the RG partial score greater than for
the normal average subject.
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Although this patient regularly underwent medical revisions and was monitored by an endocrinologist, who
prescribed the insulin treatment, his first visit to an ophthalmologist dated from 2 years before this study,
when serious loss of visual function was apparent in almost all the optometric tests.
Patient G1
A 53-year-old woman who, during routine revisions, presents intraocular pressure values between 20 and
24 mmHg and a high pachymetric value (580 μm). The left eye was examined. The basic ophthalmic
exploration data are within normal limits (VA, tonometry, anterior/posterior segment) [Fig. 1c]. The
subject shows normal color discrimination.
Patient G2
A 49-year-old woman, who had been diagnosed with chronic glaucoma a year prior to the study,
undergoing antihypertensive therapy in both eyes. The right eye was examined. The basic ophthalmic
exploration data are within normal limits (VA, tonometry, anterior segment). However, typical ocular signs
of glaucoma could be observed in the fundus image obtained by retinography [Fig. 1d]: The papilla was
excavated (with an approximate ratio of 7/10) and the “bayonet sign” could be seen in some of the
emerging vessels of the papilla.
The TES is outside the 95% confidence interval of the normal sample in the same age range (P < 0.05),
and color discrimination is low both along the RG and the BY axes.
Perimetry tests
The total deviation and pattern deviation maps for each of the perimetry tests used and each patient can be
seen in Figs. 2–5. The global parameters of each perimetry have been presented in Table 1. Analysis of the
results shows that the clinical manifestations presented by the two diabetes and two glaucoma patients have
not been the same in all tests studied. Patients labeled “1” to indicate an incipient state (D1 and G1), that
do not show obvious physical signs in optical coherence tomography (OCT) or fundus eye, have obtained
normal results both on the FM-100 Hue test and in SAP. With the multichannel perimeter, the mean
sensitivity of the patient may even be better than the average normal subject, except with the Ap tests (for
which sensitivity is worse than average, although remaining within normal limits) [Table 1], in BY
perimetry for D1 (which shows significant loss) and some points with significant absolute and relative
losses in the chromatic channels for G1. Patients labeled “2” to indicate a more advanced state (D2 and
G2), yield significant signs of pathology with all perimetric tests and retinography [Figs. 3 and 5], but both
have normal OCT, and only G2 has a nonnormal result on the FM test.
In both diabetic patients, the MD value indicates a significant pathological result for the BY stimulus [
Table 1], in agreement with the literature.[16,17,18,19] In addition, the D2 patient has a significant
absolute sensitivity loss and abnormal visual field irregularity only in the two achromatic stimuli [Fig. 3].
In the rest of the tests, in spite of the presence of abnormal points in the visual field, the global parameters
remain within normal limits.
In the G1 patient, MD values are normal in both chromatic perimetric tests, but RG shows more points
with relative sensitivity losses [Fig. 4], in agreement with the literature that shows that this mechanism is
usually selectively affected by this pathology.[20,21,22,23,24,25,26,27,28,29] With the G2 patient, all
perimetric tests exhibit significant losses in MD and the shape of the visual field is also abnormal [Fig. 5].
For all patients in the study, we can highlight a common behavior in the MD values obtained for the Ap
stimulus, that indicate sensitivity values below the average normal subject, even when the subject is above
average with other tests, although MD is outside normal limits only in the patients D2 and G2.
The results of perimetric testing derived by the multichannel perimeter have been compared with the
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results obtained with conventional achromatic SAP, already validated and used in routine clinical practice.
The areas of loss of sensitivity obtained from the two different techniques are not always the same, except
at the points of greatest loss of sensitivity, where both techniques match. The results in the chromatic (RG
for G1, BY for D1) and achromatic perimetry tests of parvocellular origin (G1 and D1) show that losses of
sensitivity were detected which were not revealed by SAP.
Discussion
It would seem that for the two patients without eye fundus damage, D1 and G1, more information was
obtained from the chromatic mechanisms than from studying sensitivity using conventional achromatic
perimetry. The two patients in the advanced stage of the pathology (D2 and G2), were used to check that
the technique did detect serious loss of visual function. The contributions of the technique to the
knowledge of the visual system of the patients have two aspects: In the first place, to determine what
visual mechanisms, if any, are more impaired at a given point of the pathology, and in the second place to
search for stimuli that would help to monitor the progression of the pathology. The comparative study of
the four tested visual mechanisms might allow a more complete analysis of the effects of the pathology
and the treatments the patient is receiving, and this we hope may help to minimize their adverse effects. At
present, this is a work in progress.
However, we have to be careful when making this kind of statements about the usefulness of different
diagnosis techniques. In the literature, there is no agreement as to the evidence that some techniques are
more sensitive than others. There are works that show that measurements that favor the magno[30,31,32] or
the koniocellular[30,31] mechanisms may be more sensitive for the early detection of pathologies than
SAP. However, other studies have found similar glaucoma detection capabilities with SAP, short
wavelength automated perimetry,[33,34] frequency doubling technology.[33,34,35] A given disease does
not usually affect a single cell type, so a patient can be diagnosed with a particular technique and yet to
appear as normal with another. However, although it seems unlikely that a single technique may be found
that is sensitive and specific for an entire particular pathological population,[36] it is nonetheless important
not to miss an early sign of functional loss. Combining different techniques instead of relying on a single
test, although time-consuming, seems the only solution at present. For these two particular patients,
relevant information would have been lost if only SAP had been performed. The difficulty lies in the
possible low repeatability of the tests-see Monhart[5] for a review of standard techniques and de Fez et
al.[7] for the repeatability of the multichannel perimeter-and in the reduced dynamic range for certain
stimuli, particularly chromatic stimuli generated in a computer-controlled screen (again, see Monhart[5]).
We have shown that certain stimulus of the multichannel perimeter detects functional loss in subjects with
glaucoma, optic nerve glaucoma suspects, and ocular hypertensive patients,[9] and that the technique
yields repeatable results.[7] If we admit, therefore, that a multichannel perimetry technique could help in
the possible early detection of the loss of functionality of the visual system, it would be appropriate to
focus on what are the particular visual mechanisms more useful to study patients that still may not
manifest loss with conventional perimeters and on the parameters of the stimuli that would be optimal for
patient follow-up. We are still following this line of research with the purpose of analyzing a broader
population that allows verification of the statistical significance.
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Figures and Tables
Figure 1
Retinography results for the four patients: (a) D1, (b) D2, (c) G1, (d) G2. The arrows signal the presence of scattered
microaneurysms, hard exudates or pinpoint hemorrhages
Table 1
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Global indexes for the different perimetric tests: MD’ and LV values for SAP and MD and PSD for the
four stimuli of multichannel perimetry, Am, Ap, RG, and BY
Figure 2
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Results for patient D1, left: Total deviation map, right: Pattern deviation map. (a) static automated perimetry, (b-e)
multichannel perimetry results with Am, Ap, RG and BY stimuli
Figure 3
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Results for patient D2, left: Total deviation map, right: Pattern deviation map. (a) static automated perimetry, (b-e)
multichannel perimetry results with Am, Ap, RG and BY stimuli
Figure 4
Chromatic-achromatic perimetry in four clinic cases: Glaucoma and diabetes
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Results for patient G1, left: Total deviation map, right: Pattern deviation map. (a) static automated perimetry, (b-e)
multichannel perimetry results with Am, Ap, RG and BY stimuli
Figure 5
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Results for Patient G2, left: Total deviation map, right: Pattern deviation map. (a) static automated perimetry, (b-e)
multichannel perimetry results with Am, Ap, RG and BY stimuli
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